To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)
If FDA is unable to post the background material on its website prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting and on FDAs website at the time of the advisory committee meeting
Heres more information
GLP-1in faydalar GLP-1 agonistlerinin en byk faydas kan ekerini gvenli ekilde drmesidir
00:00 Intro 00:51 What GLP-1 drugs treat 01:40 Reducing calories and activating AMPK 02:40 Benefits of activating AMPK 04:18 Omega-3 fatty acids and polyphenols also needed for AMPK activation 06:17 Insulin Resistance
The medication's effects on appetite and digestion fade once it is no longer in the body